Pharmaceuticals Pharmaceutical Research and Manufacturers of America (PhRMA) hired Altrius Group to lobby on a proposal to expand the World Trade Organization waiver on certain intellectual property protections for COVID-19 vaccines to include additional COVID-19 treatments. The pharmaceutical industry trade group called the proposed waiver expansion “harmful and unnecessary,” saying it could threaten innovation, jobs…